The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback